Status:
COMPLETED
Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection
Lead Sponsor:
Professor Michael Bourke
Conditions:
Colonic Polyps
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The investigators have recently become proficient in a new, and we believe more effective technique for polyp removal. Known as Endoscopic Submucosal Dissection (ESD). ESD involves removing the polyp ...
Detailed Description
EMR is a very effective procedure for lesions smaller than 20 mm. With this size the polyp can be removed en bloc. En bloc resection is preferred as it minimises the likelihood of residual adenoma and...
Eligibility Criteria
Inclusion
- Can give informed consent to trial participation
- Lesion size 20 mm to 50 mm
- Laterally spreading or sessile polyp morphology
Exclusion
- Previous resection or attempted resection of target adenoma lesion
- Endoscopic appearance of invasive malignancy
- Age less than 18 years
- Pregnancy
- Active Inflammatory colonic conditions (e.g. inflammatory bowel disease)
- Use of anticoagulant or antiplatelet agents other than aspirin less than 5 days prior to procedure
- American Society of Anesthesiology (ASA) Grade IV-V
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02198729
Start Date
July 1 2014
End Date
May 1 2019
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westmead Endoscopy Unit
Westmead, New South Wales, Australia, 2145